The NIH will accelerate research on opioid addiction and alternatives and will partner with the private sector to develop nonaddictive pain treatments, said NIH Director Francis Collins. Agency plans call for spending $1.1 billion on research this fiscal year, which includes the additional $600 million allocated by Congress.
A study in the journal BMJ Case Reports details how a participant in a hot-pepper-eating contest was hospitalized with severe headaches after eating a Carolina Reaper pepper. One of the lead authors on the report, who is a doctor at Detroit's Henry Ford Hospital, and the neurologist on the patient's case have determined that the capsaicin in the pepper likely caused blood vessels in the man's brain to constrict temporarily, causing the problem.
A study in the journal Cephalalgia found use of single-pulse transcranial magnetic stimulation, which involves self-administered magnetic pulses from a hand-held device, for treating debilitating migraines led to an average of three fewer headaches a month, regardless of what type the headache was. The findings, based on 263 patients ages 18 to 65 years who kept a headache diary for a month and self-administered magnetic pulses, also showed 46% of the participants cut their headache frequency in half.
Researchers who followed 600 veterans found those who cut back on opioid medications or switched to a non-opioid drug or therapy still had pain at levels comparable to when they relied mostly on opioids, according to a study to be presented at the Society of Behavioral Medicine conference. Researchers said the data show pain may not increase for patients who stop taking opioid drugs.
A recent FDA analysis found that a single day's worth of opioid pain drugs is adequate for pain following most outpatient procedures, but many doctors and dentists continue to prescribe 30-day supplies, FDA Commissioner Scott Gottlieb said. Physicians need to be educated on the latest research, and training should be a condition of obtaining a Drug Enforcement Administration license to prescribe controlled substances, Gottlieb said.
A report in the Journal of the American Medical Association said ischemic heart disease was the leading cause of death in the US from 1990 to 2016, while the overall mortality rate decreased. There were wide disparities in disease burden, with increases in opioid use disorders and decreases in breast cancer mortality, while high blood pressure, blood glucose and body mass index, along with poor diet and alcohol and drug use, each accounted for more than 5% of risk-attributable disability-adjusted life years in 2016.
The online recording is a valuable reference compiling 26.5 hours of synchronized audio recordings and slides of educational sessions, SIG meetings, and presentations by award recipients at the 2018 Scientific Summit in Anaheim, CA, and available for streaming. Summit attendees will receive the recording with their full meeting registration. Learn more.
The American Pain Society (APS) endorsed aggressive action by the National Institutes of Health to accelerate scientific solutions to help resolve the nation's opioid crisis by doubling funding for research on opioid misuse and pain management. Learn more.
There is nothing stronger than those two: patience and time. They will do it all.